Delivery Order SPE2DB22D3301-SPE2DB24FX7SW
Award Date
12/27/23
Potential Completion Date
12/28/23
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,004.76 firm fixed-price delivery order, awarded on May 3, 2024, has an ultimate completion date of May 6, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,451.13 firm fixed price delivery order is for the supply of XELJANZ 10 MG tablet pharmaceuticals. The contract has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,415.81 and a completion date of February 4, 2025. It is a Firm Fixed Price Delivery Order contract for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET, which is used for various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,473.31 fixed-price delivery order has a completion date of December 1, 2023 and was awarded on November 30, 2023. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO, valued at $3,437.93, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of February 13, 2024. This award is part of Amerisourcebergen's broader pharmaceutical and medical supply contracts with the federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $31,560.49 Firm Fixed Price Delivery Order for medical supplies, specifically the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 4, 2023. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military...
This federal contract award, valued at $27,782.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,005.04 firm-fixed-price delivery order provides the DLA with the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for delivering a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,678.97 delivery order contract is for XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $12,678.97 and a completion date of February 29, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,650.81 firm fixed-price delivery order is for the supply of the pharmaceutical drug Xeljanz XR 11 mg tablets. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...